TiO₂-Chitosan Hybrid Materials for Drug Delivery Applications: Conjugation Reaction with a Model Drug and Evaluation of the Functional Properties.


Journal

Journal of nanoscience and nanotechnology
ISSN: 1533-4899
Titre abrégé: J Nanosci Nanotechnol
Pays: United States
ID NLM: 101088195

Informations de publication

Date de publication:
01 05 2021
Historique:
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 12 6 2021
Statut: ppublish

Résumé

The combination of TiO₂ and chitosan is known to allow the achievement of implantable devices which combines the mechanical properties of TiO₂, with the presence of chitosan, which ensures antibacterial properties combined with an in-situ drug-delivery of biomolecules physisorbed and/or covalently linked to chitosan. In this study, 5-aminofluorescein (5-AF), a derivative of fluorescein containing a primary amino group, has been used as model molecule to simulate a drug. This dye is characterized by low cost and low toxicity, and due to its high molar absorptivity it can easily be detected by means of absorption and emission spectroscopies. The combination of 5-AF and maleic anhydride (MA) with TiO₂-chitosan materials has generated a range of novel hybrid materials tailored to applications in localized stimuli-responsive drug delivery systems. Maleic anhydride has been used as pH sensitive spacer for the covalent functionalization of the TiO₂-chitosan hybrid with MA as linker molecule. This functionalization allowed to obtain a pH-sensitive hybrid material. The efficiency of the functionalization has been verified by means of different physico-chemical characterization techniques. The behaviour of the functionalized materials is related to different parameters, among which the ratio between physisorbed/coordinated and chemisorbed 5-AF and the matrix degradation. Moreover, delivery tests in simulated body solutions at different pH have been performed showing a pH-sensitive drug delivery behaviour and indicating that the release of 5-AF is favoured at basic pH.

Identifiants

pubmed: 33653455
doi: 10.1166/jnn.2021.19050
doi:

Substances chimiques

Pharmaceutical Preparations 0
titanium dioxide 15FIX9V2JP
Chitosan 9012-76-4
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2892-2900

Auteurs

Giuseppina Cerrato (G)

Dipartimento di Chimica & Centro Interdipartimentale NIS (Nanostructured Interfaces and Surfaces) Università di Torino & Consorzio Interuniversitario Nazionale per la Scienza a la Tecnologia dei Materiali-Unità di Ricerca di Torino, via P. Giuria 7, 10125 Torino, Italy.

Gianmario Martra (G)

Dipartimento di Chimica & Centro Interdipartimentale NIS (Nanostructured Interfaces and Surfaces) Università di Torino & Consorzio Interuniversitario Nazionale per la Scienza a la Tecnologia dei Materiali-Unità di Ricerca di Torino, via P. Giuria 7, 10125 Torino, Italy.

Guido Viscardi (G)

Dipartimento di Chimica & Centro Interdipartimentale NIS (Nanostructured Interfaces and Surfaces) Università di Torino & Consorzio Interuniversitario Nazionale per la Scienza a la Tecnologia dei Materiali-Unità di Ricerca di Torino, via P. Giuria 7, 10125 Torino, Italy.

Michela Signoretto (M)

Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari Venezia & Consorzio Interuniversitario Nazionale per la Scienza a la Tecnologia dei Materiali-Unità di Ricerca di Venezia, via Torino 155, 30172 Mestre Venezi, Italy.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Aspergillus Hydrogen-Ion Concentration Coculture Techniques Secondary Metabolism Streptomyces rimosus
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH